These contradictory results in different types of cancer reveal that the complexity and heterogeneity in tumors and that Siglec15 and PD-L1 may be simultaneously regulated by other molecules in COAD; this line of research needs to be further investigated in future studies. This evidence concerns the gene SIGLEC15 and cancer.